Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational genomics of osteoarthritis in 1,962,069 individuals.

Nature·2025
Same author

The role of plasma concentrations and drug characteristics of beta-blockers in fall risk of older persons.

Pharmacology research & perspectives·2023
Same author

Novel Genetic Determinants of Dental Maturation in Children.

Journal of dental research·2022
Same author

Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults.

PloS one·2022
Same author

Genome-wide analysis of mitochondrial DNA copy number reveals loci implicated in nucleotide metabolism, platelet activation, and megakaryocyte proliferation.

Human genetics·2021
Same author

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.

NPJ precision oncology·2021

Related Experiment Video

Updated: Jul 16, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study.

M P S Sie1, F U S Mattace-Raso, A G Uitterlinden

  • 1Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.

Journal of Human Hypertension
|March 16, 2007
PubMed
Summary

Genetic variations in transforming growth factor beta1 (TGF-β1) were examined for their link to arterial stiffness. This study found no significant association between specific TGF-β1 gene polymorphisms and measures of arterial stiffness in a large population.

More Related Videos

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

Related Experiment Videos

Last Updated: Jul 16, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

Area of Science:

  • Cardiovascular Genetics
  • Vascular Biology
  • Molecular Epidemiology

Background:

  • Arterial stiffness is a key indicator and risk factor for cardiovascular disease.
  • Transforming growth factor beta1 (TGF-β1) plays a crucial role in vascular wall function, affecting angiogenesis, endothelial cells, and the extracellular matrix.
  • Investigating genetic factors influencing vascular health is essential for understanding cardiovascular disease pathogenesis.

Purpose of the Study:

  • To investigate the association between five functional polymorphisms in the transforming growth factor beta1 (TGF-β1) gene and arterial stiffness.
  • To analyze the relationship between TGF-β1 genotypes and haplotypes with arterial stiffness parameters, including pulse wave velocity (PWV), distensibility coefficient (DC), and pulse pressure (PP).
  • To determine if specific genetic variations in TGF-β1 contribute to the development or progression of arterial stiffness.

Main Methods:

  • A population-based study including 3863 participants from the Rotterdam Study.
  • Genotyping of five functional polymorphisms in the TGF-β1 gene: -800 G/A, -509 C/T, codon 10 Leu/Pro, codon 25 Arg/Pro, and codon 263 Thr/Ile.
  • Statistical analyses using analysis of variance (ANOVA) and linear regression, adjusted for relevant covariates, to assess the association between genotypes/haplotypes and arterial stiffness measures (PWV, DC, PP).

Main Results:

  • No significant associations were found between the TGF-β1 polymorphisms (-800 G/A, -509 C/T, codon 10, codon 25) and pulse wave velocity (PWV).
  • These specific TGF-β1 polymorphisms were also not associated with the distensibility coefficient (DC) or pulse pressure (PP).
  • Haplotype-based analyses confirmed the lack of association between TGF-β1 genetic variations and arterial stiffness parameters.

Conclusions:

  • The investigated functional polymorphisms in the transforming growth factor beta1 (TGF-β1) gene (-800 G/A, -509 C/T, codon 10 Leu/Pro, and codon 25 Arg/Pro) are not associated with arterial stiffness.
  • These findings suggest that common genetic variations in TGF-β1 may not be a significant determinant of arterial stiffness in the general population.
  • Further research may be needed to explore other genetic or environmental factors influencing arterial stiffness and cardiovascular disease risk.